Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
103.8 USD | +0.26% | -2.07% | +2.99% |
07:08pm | US FDA sends warning to Cardinal Health for marketing unapproved devices | RE |
Apr. 24 | Evercore ISI Adjusts Cardinal Health's Price Target to $110 From $118, Keeps In Line Rating | MT |
Financials (USD)
Sales 2024 * | 225B | Sales 2025 * | 238B | Capitalization | 25.18B |
---|---|---|---|---|---|
Net income 2024 * | 1.21B | Net income 2025 * | 1.54B | EV / Sales 2024 * | 0.11 x |
Net cash position 2024 * | 436M | Net cash position 2025 * | 1.34B | EV / Sales 2025 * | 0.1 x |
P/E ratio 2024 * |
18.1
x | P/E ratio 2025 * |
15.5
x | Employees | 47,520 |
Yield 2024 * |
1.96% | Yield 2025 * |
1.99% | Free-Float | 74.12% |
Latest transcript on Cardinal Health, Inc.
1 day | +0.64% | ||
1 week | -1.68% | ||
Current month | -6.86% | ||
1 month | -6.12% | ||
3 months | -1.41% | ||
6 months | +11.43% | ||
Current year | +3.39% |
Managers | Title | Age | Since |
---|---|---|---|
Jason Hollar
CEO | Chief Executive Officer | 51 | 20-04-26 |
Aaron Alt
DFI | Director of Finance/CFO | 53 | 23-02-09 |
Michelle Greene
CTO | Chief Tech/Sci/R&D Officer | 54 | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 55 | 22-09-05 | |
Director/Board Member | 71 | 13-09-11 | |
Gregory Kenny
CHM | Chairman | 71 | 06-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 103.8 | +0.26% | 1 629 485 |
24-04-24 | 103.5 | +0.16% | 2,057,344 |
24-04-23 | 103.4 | +0.53% | 2,477,426 |
24-04-22 | 102.8 | -4.95% | 5,287,253 |
24-04-19 | 108.2 | +2.07% | 1,486,096 |
Delayed Quote Nyse, April 25, 2024 at 01:31 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.39% | 25.18B | |
+17.02% | 70.36B | |
+6.36% | 8.61B | |
+6.46% | 8.14B | |
-21.01% | 7.83B | |
-0.61% | 4.56B | |
+17.12% | 4.32B | |
-0.14% | 4.06B | |
-3.30% | 3.87B | |
+21.70% | 3.61B |
- Stock Market
- Equities
- CAH Stock